| __timestamp | Arrowhead Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 11768000 |
| Thursday, January 1, 2015 | 57410147 | 15152000 |
| Friday, January 1, 2016 | 41454452 | 19828000 |
| Sunday, January 1, 2017 | 31690298 | 25573000 |
| Monday, January 1, 2018 | 52968505 | 23634000 |
| Tuesday, January 1, 2019 | 81048686 | 38845000 |
| Wednesday, January 1, 2020 | 128874979 | 50523000 |
| Friday, January 1, 2021 | 206342000 | 75463000 |
| Saturday, January 1, 2022 | 297307000 | 105767000 |
| Sunday, January 1, 2023 | 353188000 | 167512000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. have been at the forefront of this race. From 2014 to 2023, Arrowhead has consistently outpaced Xenon in research and development (R&D) spending, with a staggering 220% increase in their R&D budget, peaking at over $500 million in 2024. In contrast, Xenon has shown a steady growth, reaching its highest R&D expenditure of approximately $168 million in 2023. This trend highlights Arrowhead's aggressive push towards innovation, while Xenon maintains a more measured approach. The data suggests that Arrowhead's strategy may be positioning them as a leader in pharmaceutical advancements, though Xenon's consistent growth indicates a strong commitment to innovation as well. Missing data for 2024 for Xenon suggests a potential shift or pause in their investment strategy.
Research and Development Expenses Breakdown: argenx SE vs Xenon Pharmaceuticals Inc.
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Incyte Corporation vs Xenon Pharmaceuticals Inc.
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Insights: How Ascendis Pharma A/S and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Perrigo Company plc vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Xenon Pharmaceuticals Inc. and ImmunityBio, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Arrowhead Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.